跳到主要內容

電解質補充 electrolyte supplement

 電解質補充 electrolyte supplement

以下內容部分來自經驗,部分來自資料庫,僅供參考

藥物

敘述

低血鈉

Normal saline

一般低血鈉用500 ml生理食鹽水即可,盡量不要用3% saline

Sodium chloride 3%

經驗3% saline 50ml and run 8ml/hr,病人血鈉從127爬升到136 mEq/L,可用0.5 ml/kg/day去補比較安全

***注意每天補不得超過6-8 mEq/L以防產生central pontine myelinolysis/osmotic demyelination syndrome

 

Uptodate

l   Asymptomatic, acute serum sodium <130 mEq/L —usually treat with a 50 mL bolus of 3 percent saline (ie, hypertonic saline) to prevent the serum sodium from falling further

l   Symptomatic (seizures, obtundation, coma, respiratory arrest, headache, nausea, vomiting, tremors, gait or movement disturbances, or confusion), acute serum sodium <130 mEq/L—100 mL bolus of 3 percent saline, followed, if symptoms persist, with up to two additional 100 mL doses (to a total dose of 300 mL); each bolus is infused over 10 minutes.

l   Severe symptoms or known intracranial pathology — In all patients with severe symptoms of hyponatremia (eg, seizures, obtundation, coma, respiratory arrest), 100 mL bolus of 3% saline followed, if symptoms persist, by up to two additional 100 mL doses (to a total dose of 300 mL); each bolus is infused over 10 minutes .

l   Patients with severe chronic hyponatremia (serum sodium <120 mEq/L) —initiate intravenous 3% saline beginning at a rate of 15 to 30 mL/hour, administered via a peripheral vein; we use 3 percent saline (rather than normal saline) in patients with and without suspected hypovolemia.

低血鉀

K-supply tab, potassium gluconate, 2.54 mEq

可以3# TID使用,藥物很大顆。

K-Glu oral solution, potassium gluconate, 20 mEq

可以1# TID使用,不是很好喝。

KCl 20 mEq in 500 ml normal saline

個人經驗用在血鉀 < 3 mEq/L

<2.5 mEq/L的時候可以BID2-3

< 3 mEq/L>2.5 mEq/LQD補充3

KCl 20mEq in 100 ml normal saline

濃度高,從central line給予。

低血鈣

Vitacal, 2% calcium chloride in 20ml 10% glucose solution

total 400 mg calcium chloride

total 108 mg elemental calcium

一支可以補大概0.5 mg/dlcorrected serum calcium

用於corrected serum calcium <= 7.5 mg/dl free calcium <= 0.8 mmol/L

Calcium carbonate tab 500 mg

total 200 mg elemental calcium

1# BID-QID, 也可2# QD-BID

Bio-cal plus chewable tab [Tricalcium phosphate 1203 mg + cholecalciferol (D3) 330 IU]

total 450 mg elemental calcium

2-3# QD

All-right calcium suspension

Ca3(PO4)2 + vitamin A + vitamin D3

40 mg elemental calcium + 40 mcg vitamin A + 4 mcg vitamin D4 / ml

10-15 ml/day

Uptodate

l   Asymptomatic, corrected serum calcium > 7.5 mg/dl free calcium > 0.8 mmol/L:口服

l   Asymptomatic, corrected serum calcium <= 7.5 mg/dl free calcium <= 0.8 mmol/L90-180 mg elemental calcium over 10 to 20 minutes,約等於1# vitalcal

l   Acute, symptomatic:補200-1,000 mg calcium chloride QD

l   Severe, symptomatic (eg, seizure, tetany):補充1,000 mg calcium chloride over 10 minutes; repeat every 60 minutes until symptoms resolve

l   補鉀的時候,若要同時補bicarbonate或磷,需要從另一條管路給予

低血磷

酵母粉yeast powder

Phosphate 1477 mg (15.6 mmol)/100 g

2 spoon TID

參考病人吃三天,血磷從1.3爬到2

Neutral phosphate

4.5 g elemental phosphate (47 mmol)

1.2-1.5 g daily

但可以吃到 3 g daily以上

*** 65 kg F 血磷 0.9 mg/dl,補 1 g TID,隔天4.7 mg/dl

(此病人有lung adenocarcinoma w/ bone mets c/w hypocalcemia及central DI)

Potassium phosphate 20 ml

1860 mg (60 mmol) elemental phosphate

88 mEq elemental potassium

使用時要密切監控,建議在加護病房使用,使用時從中心靜脈導管給予,0.5 #500 ml normal saline跑兩小時

***經驗則是0.25# in 250 ml NS, run 12 hr

Uptodate

l   Asymptomatic patients with a serum phosphate < 2.0 mg/dL (0.64 mmol/L):口服補充,因症狀及肌肉病變在此時可能不明顯

l   Symptomatic patients with a serum phosphate between 1.0 to 1.9 mg/dL (0.32 to 0.63 mmol/L):口服補充

l   Symptomatic patients with a serum phosphate < 1.0 mg/dL (0.32 mmol/L):點滴補充,當補到1.5 mg/dL時改成口服

l   治療劑量給予方式

n   serum phosphate >= 1.5 mg/dL (0.48 mmol/L)1 mmol/kg of elemental phosphorus (minimum of 40 mmol and a maximum of 80 mmol)一天內分成三四次給予(腎臟功能不佳需減半)

n   serum phosphate < 1.5 mg/dL (0.48 mmol/L)1.3 mmol/kg of elemental phosphorus (a maximum of 100 mmol)一天內分成三四次給予(腎臟功能不佳需減半)

n   serum phosphate >= 1.25 mg/dL (0.40 mmol/L)0.08-0.24 mmol/kg over 6 hours (up to a maximum total dose of 30 mmol)

n   serum phosphate < 1.25 mg/dL (0.40 mmol/L)0.25-0.50 mmol/kg over 8 to 12 hours (up to a maximum total dose of 80 mmol)

低血鎂

Magnesium oxide 250 mg

Asymptomatic1# TID-QID

(5-10 mg/kg)

Magnesium sulfate 10% 20 ml

16.24 mEq/amp

Uptodate

l   Non severe32 to 64 mEq (16 to 32 mmol) IVD over 24 hours

l   hemodynamically stable patients with severe symptomatic hypomagnesemia (<= 1 mg/dL [0.4 mmol/L or 0.8 mEq/L])8-16 mEq (4-8 mmol) in 50-100 D5W IVD in 5-60 minutes followed by infusion

l   Severe, hemodynamically unstable pts  (including those with arrhythmias consistent with torsade de pointes or hypomagnesemic hypokalemia): 8-16 mEq (4-8 mmol) IVD in 10-15 minutes

 

參考案例
samll bowel obstruction住院
(理由不明,沒有手術hx)
NPO超過20天以上
5/24日開始灌食(當天1000kcal, BW 50.4kg)
昨天拉了6次大便,黃軟便
今天抽血(超過一個月沒抽血)
Na: 131
K: 2.0
IP: 1.4
Mg: 1.29
free Ca: 0.89 mmol/L
Hx: HF, HTN, PAOD
r/o refeeding syndrome
 
建議處置可能如下
熱量10kcal/kg=> 500kcal給起
KCl 20mEq BID 2
vitacal 1# QD 4
mag. sulfate 1# once
yeast powder 2 spoons TID $
vitamin B1 1# BID 5
 

留言

這個網誌中的熱門文章

COVID-19疫苗施打對象

  COVID-19 疫苗施打對象 l    施打禁忌症 n    兒童 (< 18 歲 ) : 包含 mRNA-1273 (Moderna COVID-19 vaccine) 、 ChadOx1 nCoV-19/AZD1222 (AstraZeneca COVID-19 vaccine) 、 Ad26.COV2.S (Janssen COVID-19 vaccine, also referred to as the Johnson & Johnson vaccine) n    <12 歲 : BNT162b2 (Pfizer-BioNTech COVID-19 vaccine) n    第一劑疫苗產生嚴重過敏反應,特別注意可能有 cross reaction l    特別族群 n    有 血栓併發血小板低下 ( 包含肝素引起之血小板低下 ) 等狀況,避免施打 ChadOx1 nCoV-19/AZD1222 (AstraZeneca COVID-19 vaccine) 和 Ad26.COV2.S (Janssen COVID-19 vaccine) ,建議施打 mRNA 疫苗 n    孕婦 ,因為較一般人更容易併發重症,建議施打 mRNA 疫苗,如果沒有,就挑選其他疫苗 n    哺乳中 可以施打 n    對 雞蛋或牛奶過敏者 可以施打 n    曾確診 COVID-19 之病人 可以施打 n    免疫不全者 可以施打 n    蠶豆症 可以施打 n    服用抗病毒藥物者 可以施打 n    服用避孕藥、調經藥者 可以施打 n    風濕免疫科相關 u   施打後停藥 1 週: mycophenolate 山喜多、 methotrexate 滅殺除癌錠 ( 若打 AstraZeneca COVID-19 vaccine 及 mRNA vaccine) 、 ...

重症病人新發心房纖維性顫動之處理management of new-onset atrial fibrillation during critical illness

重症病人新發心房纖維性顫動之處理 management of new-onset atrial fibrillation during critical illness   參考 Bosch, N. A., Cimini, J., & Walkey, A. J. (2018). Atrial fibrillation in the ICU. Chest, 154(6), 1424-1434.

恢復室的進出 disposition of post-anesthesia care unit (recovery room)

恢復室的進出    disposition of post-anesthesia care unit (recovery room)   l    Admission 除了局部麻醉 (local anesthesia) 之外,只要被麻醉的病人都需要到恢復室,包含全身麻醉 (GA 、 IVGA) 、半身麻醉 (SA) 。 l    監控 Vital sign 就包含心跳、血壓、血氧、心電圖,如果病人有動脈導管,則可用其監測相關數值。 l    Discharge n    全身麻醉 若病人 PAR scroe( 以下表格 ) 達到 9-10 分可以離開恢復室, 9 分只能是少循環的那一分,若是其他項目依然繼續觀察或處置。 項目 分數 內容 活動 activity 2 可以根據指令自由移動四肢 1 可以根據指令自由移動其中兩肢 0 無法移動 呼吸 respiration 2 可以吸個夠深且自由咳嗽 1 呼吸困難或呼吸緩慢 0 呼吸暫停 循環 circulation 2 血壓在術前血壓± 20% 內 1 血壓在術前血壓± 20-50% 內 0 血壓在術前血壓超過± 50% 意識 consciousness 2 完全清醒 1 可以被喚醒 0 沒有反應 血氧 oxygen 2 SpO 2 ≥ 94% ...